Scotia Capital Inc. Has $472,000 Stake in Stryker Co. (SYK)
Scotia Capital Inc. decreased its position in shares of Stryker Co. (NYSE:SYK) by 52.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,048 shares of the medical technology company’s stock after selling 3,420 shares during the quarter. Scotia Capital Inc.’s holdings in Stryker were worth $472,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Truewealth LLC acquired a new position in shares of Stryker during the fourth quarter valued at $110,000. Sawyer & Company Inc acquired a new stake in Stryker in the fourth quarter worth about $125,000. Sit Investment Associates Inc. lifted its holdings in Stryker by 114.3% in the fourth quarter. Sit Investment Associates Inc. now owns 825 shares of the medical technology company’s stock worth $128,000 after purchasing an additional 440 shares during the period. Oak Point Wealth Management acquired a new stake in Stryker in the fourth quarter worth about $145,000. Finally, San Francisco Sentry Investment Group CA lifted its holdings in Stryker by 47.8% in the third quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock worth $143,000 after purchasing an additional 325 shares during the period. 75.71% of the stock is owned by institutional investors.
Shares of Stryker Co. (NYSE SYK) opened at $167.89 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.29 and a quick ratio of 1.59. Stryker Co. has a 1 year low of $129.59 and a 1 year high of $170.00. The company has a market cap of $62,344.18, a PE ratio of 62.65, a price-to-earnings-growth ratio of 2.39 and a beta of 0.70.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, April 30th. Shareholders of record on Thursday, March 29th will be issued a dividend of $0.47 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $1.88 annualized dividend and a yield of 1.12%. Stryker’s payout ratio is presently 70.15%.
SYK has been the subject of several research analyst reports. ValuEngine raised shares of Stryker from a “hold” rating to a “buy” rating in a report on Tuesday, November 14th. Robert W. Baird raised shares of Stryker from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $161.00 to $173.00 in a report on Thursday, November 16th. SunTrust Banks reaffirmed a “buy” rating and issued a $161.00 price objective on shares of Stryker in a report on Friday, November 17th. Needham & Company LLC reaffirmed a “hold” rating on shares of Stryker in a report on Thursday, December 7th. Finally, BMO Capital Markets raised shares of Stryker to a “market perform” rating and set a $163.00 price objective for the company in a report on Tuesday, December 12th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and fifteen have issued a buy rating to the company. Stryker has an average rating of “Buy” and an average target price of $163.85.
In other Stryker news, VP William E. Berry, Jr. sold 1,306 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $164.42, for a total transaction of $214,732.52. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Yin C. Becker sold 23,221 shares of the business’s stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $165.96, for a total value of $3,853,757.16. Following the sale, the vice president now owns 10,499 shares in the company, valued at approximately $1,742,414.04. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,611 shares of company stock worth $7,178,719. Corporate insiders own 7.40% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Scotia Capital Inc. Has $472,000 Stake in Stryker Co. (SYK)” was published by Daily Political and is the property of of Daily Political. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2018/03/13/scotia-capital-inc-has-472000-stake-in-stryker-co-syk.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.